<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-17550" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Anetoderma</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cook</surname>
            <given-names>Jordan C.</given-names>
          </name>
          <aff>LewisGale Hospital Montgomery</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Puckett</surname>
            <given-names>Yana</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jordan Cook declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Yana Puckett declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-17550.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Anetoderma is a benign, uncommon skin disorder of elastolysis, causing discrete focal areas of flaccid skin. Anetoderma has no racial predilection. It can be seen in people of all ages but is more common in females. Treatment of anetoderma is offered to improve cosmesis or to prevent new lesions from forming. This activity reviews the evaluation and management of anetoderma and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of anetoderma.</p></list-item><list-item><p>Describe the appropriate evaluation of anetoderma.</p></list-item><list-item><p>Outline the management options available for anetoderma.</p></list-item><list-item><p>Summarize interprofessional team strategies for improving care coordination and communication to advance the care of anetoderma and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17550&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17550">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-17550.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The term anetoderma is derived from the Greek words 'anetos', meaning relaxed, and 'derma,' meaning skin. The condition was first described by Jadassohn in 1892.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref>&#x000a0;Anetoderma is a benign disorder of elastolysis, causing well-circumscribed, focal areas of flaccid skin.&#x000a0;The localized areas of slack skin can present clinically as round to oval atrophic depressions, wrinkled macules, patches, or herniated sac-like protrusions with a surrounding border of normal skin. The lesions can be a variety of colors from skin-colored, white, grey, brown, or blue, and the size can range from millimeters to centimeters. Anetoderma most commonly presents on the trunk and proximal extremities.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref>&#x000a0;Once present, the disease tends to be active for at least 15 years.<xref ref-type="bibr" rid="article-17550.r2">[2]</xref>&#x000a0;No reports of spontaneous regression have occurred.</p>
      </sec>
      <sec id="article-17550.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Anetoderma has been classified into five different subtypes, including primary (idiopathic) anetoderma, secondary anetoderma from a preceding dermatosis, drug-induced anetoderma, familial anetoderma, and prematurity associated anetoderma. The primary type occurs in areas of previously normal skin, and this type is historically subdivided into the Jadassohn-Pellizzari type and the Schweninger-Buzzi type. The Jadassohn-Pellizzari type of anetoderma develops after preceding inflammatory or urticarial lesions transpire, while the Schweninger-Buzzi type develops in normal-appearing skin with no foreshadowing skin changes. The two primary types are identical histologically and have a similar disease course,&#x000a0;and so these terms are now antiquated.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref></p>
        <p>The secondary type of anetoderma develops in areas of pathologic skin. The most common associated dermatoses are thought to be acne vulgaris and varicella but have also occurred with other disorders such as syphilis, sarcoidosis, tuberculosis, leprosy, Lyme disease, mastocytosis, prurigo nodularis, urticaria pigmentosa, granuloma annulare, insect bites, xanthomas, pilomatricomas, cutaneous B or T-cell lymphomas,<xref ref-type="bibr" rid="article-17550.r3">[3]</xref>&#x000a0;post-hepatitis B vaccination,<xref ref-type="bibr" rid="article-17550.r4">[4]</xref>&#x000a0;hamartomatous congenital melanocytic nevi,&#x000a0;application of leeches, molluscum contagiosum, myxofibrosarcoma, and nodular amyloidosis.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref>&#x000a0;There have been reports of primary and secondary anetoderma in association with HIV-1 infection and various autoimmune diseases such as systemic lupus erythematosus, Graves disease, Addison disease, antiphospholipid syndrome, Sj&#x000f6;gren syndrome, and hemolytic anemia.<xref ref-type="bibr" rid="article-17550.r3">[3]</xref></p>
        <p>Penicillamine is the sole medication linked to drug-induced anetoderma. Penicillamine is thought to inhibit aldol-cross-linking, which is important for elastic fiber formation.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref>&#x000a0;The familial form of anetoderma is rare and has an autosomal inheritance pattern. The familial form generally develops in the first decade of life and might be evident as purely skin manifestations but can also be associated with bony, neurological, and ocular anomalies.<xref ref-type="bibr" rid="article-17550.r5">[5]</xref>&#x000a0;Anetoderma of prematurity is found in premature neonates that had been monitored in the neonatal intensive care unit with prematurity of twenty-four to twenty-nine weeks of gestational age.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref></p>
      </sec>
      <sec id="article-17550.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Anetoderma is a rare disorder with an unknown accurate prevalence. Cases have been reported from all age ranges, but it most commonly occurs in adults 20&#x000a0;to 40 years old. Anetoderma is more common in females than males and has not been found to have a racial predilection.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref></p>
      </sec>
      <sec id="article-17550.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The exact pathophysiology of anetoderma is not certain. In all types of anetoderma, there is a decrease in elastic tissue hypothesized to be from a decrease in the production of elastin, an increase in elastin degradation through an increase in elastolytic enzymes, a decrease in elastolytic enzyme inhibitors, or increased elastin phagocytosis. In penicillamine drug-induced anetoderma, aldol cross-linking is inhibited, which does not allow elastic fibers to develop normally. It has been hypothesized in anetoderma of prematurity that tissue hypoxia secondary to adhesive medical devices causes degradation of elastin by producing an increase in the expression of matrix metalloproteinases.<xref ref-type="bibr" rid="article-17550.r6">[6]</xref></p>
      </sec>
      <sec id="article-17550.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>On microscopy, the skin of anetoderma shows nearly complete loss of elastic fibers in the layers of the papillary and reticular dermis. The histopathology of lesional skin can also show a dermal periadnexal and perivascular infiltrate with histiocytes and plasma cells.<xref ref-type="bibr" rid="article-17550.r7">[7]</xref></p>
      </sec>
      <sec id="article-17550.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Early lesions of anetoderma are generally asymptomatic or pruritic erythematous macules, plaques, or nodules that enlarge until they reach their final size. They may also form in an area of pathologic skin, such as in the secondary type. The lesions may be single or multiple and are configured in discrete flaccid areas of loose, wrinkled skin that may be depressed or protruding bulges above the skin.&#x000a0;With palpation of the lesion, a normal ring of the skin can be felt on the perimeter, and centrally the lesion will herniate inward with pressure. The lesions do not change over time once the lesions become end-stage.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref></p>
      </sec>
      <sec id="article-17550.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>The diagnosis of anetoderma can be made clinically. However, if the diagnosis is not straightforward, a skin biopsy can be performed, preferably with a punch biopsy, in order to include the mid-dermis. The subtype of anetoderma should also be determined once diagnosed as anetoderma, aided by the patient&#x02019;s history.</p>
        <p>In addition to the histopathology on electron microscopy, elastophagocytosis and small fragmented elastic fibrils can be visualized in lesional skin.<xref ref-type="bibr" rid="article-17550.r8">[8]</xref><xref ref-type="bibr" rid="article-17550.r9">[9]</xref>&#x000a0;Desmosine is a major amino acid in elastin and therefore has been used to measure the concentration of elastin in lesional skin, which is significantly reduced in anetoderma.<xref ref-type="bibr" rid="article-17550.r10">[10]</xref></p>
        <p>Patients with primary anetoderma may require an additional workup to look for associated underlying diseases. The testing selected should be selected with suspicion for particular disorders based on the history and physical exam. Primary anetoderma has an association with antiphospholipid antibodies. Therefore they should always be tested for in patients diagnosed with primary anetoderma, even if history is negative for thrombotic disease or spontaneous abortions.<xref ref-type="bibr" rid="article-17550.r3">[3]</xref></p>
      </sec>
      <sec id="article-17550.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There have been various medical treatments for anetoderma reported, but none have been effective in established lesions. Colchicine has been shown to prevent new primary anetoderma lesions from forming.<xref ref-type="bibr" rid="article-17550.r11">[11]</xref>&#x000a0;In secondary anetoderma, controlling the causative dermatoses should theoretically prevent new lesions from forming.</p>
        <p>Other treatments that have been used with no studied efficacy include cryotherapy, intralesional steroids, colchicine, hydroxychloroquine, vitamin E, oral penicillin G, epsilon-aminocaproic acid, aspirin, niacin, dapsone, and phenytoin.<xref ref-type="bibr" rid="article-17550.r1">[1]</xref>&#x000a0;Established lesions can be excised for definitive treatment but will leave a permanent scar. Laser treatment may improve lesion appearance according to limited case reports.<xref ref-type="bibr" rid="article-17550.r12">[12]</xref><xref ref-type="bibr" rid="article-17550.r13">[13]</xref></p>
      </sec>
      <sec id="article-17550.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Diseases commonly mistaken for anetoderma consist primarily of disorders of elastic tissue leading to cutaneous atrophy similar to that of anetoderma.&#x000a0;Mid-dermal elastolysis has a loss of mid-dermal elastic fibers causing widespread, well-defined, thin, and wrinkled plaques commonly on the trunk and upper arms. In acquired cutis laxa, there is a loss of elastic fibers that cause the skin to have a widespread loose sagging appearance. Granulomatous slack skin disease is a rare variant of cutaneous T cell lymphoma with phagocytized elastic fibers causing findings of erythematous pendulous folds of loose skin. Atrophoderma of Pasini and Pierini present as brown, gray or violaceous macules or patches with a distinct drop-off sloping border on palpation most commonly located on the trunk.</p>
      </sec>
      <sec id="article-17550.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>After the development of anetoderma, the lesions remain stable and do not resolve over time.</p>
      </sec>
      <sec id="article-17550.s12" sec-type="Complications">
        <title>Complications</title>
        <p>In primary anetoderma associated with antiphospholipid antibodies, possible complications may occur years after diagnosis, which include thrombotic events, superficial phlebitis, and spontaneous abortions.<xref ref-type="bibr" rid="article-17550.r14">[14]</xref>&#x000a0;This is why it is important to serologically evaluate all patients with primary anetoderma for antiphospholipid antibodies irrespective of the history of thrombotic events.</p>
      </sec>
      <sec id="article-17550.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Anetoderma is a benign skin condition, and once the diagnosis has been made, it is important to identify the type of anetoderma. This helps the patient to understand the disease course and look into treating underlying factors of the secondary type of anetoderma to halt the formation of new lesions. Patients should be educated about the disease, the disease course, and the understanding that once lesions have developed, they do not resolve.</p>
      </sec>
      <sec id="article-17550.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Anetoderma is a rare disease that is best treated by an interprofessional team. The team should include primary clinicians, dermatologists, and pathologists. The primary care clinician needs to be aware of this benign condition and recognize the specific subtype of anetoderma of the patient they have under their care. Knowing the subtype will help monitor the patient for any associated disorders and help offer suitable treatments for the patient. Nurses can play a role in patient education. Strong communication within the team will help improve patient outcomes.</p>
      </sec>
      <sec id="article-17550.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=17550&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=17550">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/anetoderma/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=17550">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/17550/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=17550">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-17550.s16">
        <title>References</title>
        <ref id="article-17550.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kineston</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Turiansky</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Anetoderma: a case report and review of the literature.</article-title>
            <source>Cutis</source>
            <year>2008</year>
            <month>Jun</month>
            <volume>81</volume>
            <issue>6</issue>
            <fpage>501</fpage>
            <page-range>501-6</page-range>
            <pub-id pub-id-type="pmid">18666393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venencie</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Winkelmann</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>BA</given-names>
              </name>
            </person-group>
            <article-title>Anetoderma. Clinical findings, associations, and long-term follow-up evaluations.</article-title>
            <source>Arch Dermatol</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>120</volume>
            <issue>8</issue>
            <fpage>1032</fpage>
            <page-range>1032-9</page-range>
            <pub-id pub-id-type="pmid">6465909</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sparsa</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Piette</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Wechsler</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Amoura</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Franc&#x000e8;s</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Anetoderma and its prothrombotic abnormalities.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2003</year>
            <month>Dec</month>
            <volume>49</volume>
            <issue>6</issue>
            <fpage>1008</fpage>
            <page-range>1008-12</page-range>
            <pub-id pub-id-type="pmid">14639377</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Daoud</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Dicken</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Anetoderma after hepatitis B immunization in two siblings.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1997</year>
            <month>May</month>
            <volume>36</volume>
            <issue>5 Pt 1</issue>
            <fpage>779</fpage>
            <page-range>779-80</page-range>
            <pub-id pub-id-type="pmid">9146542</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Patrizi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neri</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Virdi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Misciali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>D'Acunto</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Familial anetoderma: a report of two families.</article-title>
            <source>Eur J Dermatol</source>
            <year>2011</year>
            <season>Sep-Oct</season>
            <volume>21</volume>
            <issue>5</issue>
            <fpage>680</fpage>
            <page-range>680-5</page-range>
            <pub-id pub-id-type="pmid">21719400</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghomrasseni</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dridi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gogly</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bonnefoix</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vabres</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Venencie</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Pellat</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Godeau</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Anetoderma: an altered balance between metalloproteinases and tissue inhibitors of metalloproteinases.</article-title>
            <source>Am J Dermatopathol</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-29</page-range>
            <pub-id pub-id-type="pmid">11979071</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venencie</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Winkelmann</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Monoclonal antibody studies in the skin lesions of patients with anetoderma.</article-title>
            <source>Arch Dermatol</source>
            <year>1985</year>
            <month>Jun</month>
            <volume>121</volume>
            <issue>6</issue>
            <fpage>747</fpage>
            <page-range>747-9</page-range>
            <pub-id pub-id-type="pmid">3873911</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Venencie</surname>
                <given-names>PY</given-names>
              </name>
              <name>
                <surname>Winkelmann</surname>
                <given-names>RK</given-names>
              </name>
            </person-group>
            <article-title>Histopathologic findings in anetoderma.</article-title>
            <source>Arch Dermatol</source>
            <year>1984</year>
            <month>Aug</month>
            <volume>120</volume>
            <issue>8</issue>
            <fpage>1040</fpage>
            <page-range>1040-4</page-range>
            <pub-id pub-id-type="pmid">6465910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zaki</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Scerri</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Primary anetoderma: phagocytosis of elastic fibres by macrophages.</article-title>
            <source>Clin Exp Dermatol</source>
            <year>1994</year>
            <month>Sep</month>
            <volume>19</volume>
            <issue>5</issue>
            <fpage>388</fpage>
            <page-range>388-90</page-range>
            <pub-id pub-id-type="pmid">7955494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oikarinen</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Palatsi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Adomian</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Oikarinen</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Clark</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Uitto</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Anetoderma: biochemical and ultrastructural demonstration of an elastin defect in the skin of three patients.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1984</year>
            <month>Jul</month>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>64</fpage>
            <page-range>64-72</page-range>
            <pub-id pub-id-type="pmid">6736354</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Braun</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Borradori</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chavaz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Masouy&#x000e9;</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>French</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Saurat</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Treatment of primary anetoderma with colchicine.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1998</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>6 Pt 1</issue>
            <fpage>1002</fpage>
            <page-range>1002-3</page-range>
            <pub-id pub-id-type="pmid">9632017</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cho</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jung</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Treatment of anetoderma occurring after resolution of Stevens-Johnson syndrome using an ablative 10,600-nm carbon dioxide fractional laser.</article-title>
            <source>Dermatol Surg</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>38</volume>
            <issue>4</issue>
            <fpage>677</fpage>
            <page-range>677-9</page-range>
            <pub-id pub-id-type="pmid">22251221</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ross</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Saedi</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Anetoderma treated with combined 595-nm pulsed-dye laser and 1550-nm non-ablative fractionated laser.</article-title>
            <source>J Cosmet Laser Ther</source>
            <year>2016</year>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>38</fpage>
            <page-range>38-40</page-range>
            <pub-id pub-id-type="pmid">25968163</pub-id>
          </element-citation>
        </ref>
        <ref id="article-17550.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hodak</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>David</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Primary anetoderma and antiphospholipid antibodies--review of the literature.</article-title>
            <source>Clin Rev Allergy Immunol</source>
            <year>2007</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>2</issue>
            <fpage>162</fpage>
            <page-range>162-6</page-range>
            <pub-id pub-id-type="pmid">17916987</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
